A press release will be transmitted to the news media immediately following the close of the market on Oct. 29. The Company will host a conference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m. PT. The webcast is accessible via the investor relations section of the Company's Web site at http://www.supergen.com. A webcast replay of the live conference call will be available for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.
Timothy L. Enns Mary M. Vegh
S.V.P., Corporate Communications Manager, Investor Relations
& Business Development (925) 560-2845
(925) 560-0100 x111 email@example.com